Hims & Hers caused a firestorm last week when it revealed that it planned to launch a knockoff version of Novo Nordisk's new ...

Hims & Hers Health, Inc. (NYSE:HIMS) is one of the Stocks With Huge Catalysts on the Horizon. On July 9, Hims & Hers Health, Inc. (NYSE:HIMS) announced expanding into Canada with a new affordable ...

MOBILE, Ala. (WALA) - More than 40% of American adults live with obesity, yet personalized, supportive care is often out of reach due to challenges like soaring costs, lack of insurance coverage, or ...

An informational overview of reported February 2026 developments, FDA-approved vs. compounded medication distinctions, Wegovy pill category context, published pricing disclosures, telehealth ...

Supported by strong balance sheet, program provides flexibility for Company to capitalize on valuation disconnects over the next three years SAN FRANCISCO--(BUSINESS WIRE)-- Hims & Hers Health, Inc.

Hims & Hers is rated Hold as regulatory/legal risks hit its GLP-1 weight-loss pivot; resilient core & strong liquidity noted. Click to read more on HIMS stock.

(RTTNews) - Hims & Hers Health, Inc. (HIMS), a health and wellness platform, on Monday announced that its board has authorized a new share repurchase program of up to $250 million in Class A common ...

Hims & Hers HIMS recently announced that it is expanding access to its comprehensive Weight Loss Program to customers in the United Kingdom. The company is launching its Hers platform to provide ...